Clinical trial
Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients
NCT04379817 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients
- Lead sponsor
- Jules Bordet Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 25, 2020
- Completion date
- May 23, 2024
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.